Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Medical Devices

Vizient contract for Seno Medical’s hybrid imaging technology to help transform breast cancer diagnosis, says GlobalData

In November 2024, Seno Medical secured an Innovative Technology contract from Vizient for its Imagio breast imaging system, a breakthrough device designed to enhance the diagnostic process for breast cancer. The system combines opto-acoustic and ultrasound imaging to provide real-time, non-invasive insights into breast masses, aiming to reduce the need for invasive biopsies. A contract […]
Read more

Legal and ethical challenges shaping AI-driven clinical trials, says GlobalData

The integration of artificial intelligence (AI) in clinical trials has transformed healthcare by enhancing data analysis, predicting outcomes, and expediting drug development. However, this innovation comes with significant legal and ethical challenges, as AI systems rely heavily on vast datasets from clinical trials, raising concerns about consent, data origin, and ethical standards, says GlobalData, a […]
Read more

Unifying political framework will unlock full potential of AI-driven healthcare, says GlobalData

Artificial Intelligence (AI) has revolutionized healthcare, enhancing diagnostics, personalizing treatments, and improving patient outcomes. The rapid adoption of AI has led to a fragmented regulatory landscape in the US. Many states have introduced AI-specific legislation addressing data privacy and cybersecurity. For instance, states like California have enacted stringent consumer protection laws limiting personal data use, […]
Read more

Arteriotomy closure devices market to reach $873 million by 2033, forecasts GlobalData

The rise in cardiovascular diseases globally has resulted in a higher number of interventional procedures, necessitating the use of arteriotomy closure devices. Arteriotomy closure devices are essential in managing access sites after procedures such as angiography or vascular interventions. Valued at $641 million in 2024, the arteriotomy closure devices market is projected to reach sales […]
Read more

RFK Jr.’s appointment as US HHS Secretary to reshape regulatory and market landscape of medical devices, says GlobalData

The appointment of Robert F. Kennedy Jr. as Secretary of Health and Human Services (HHS) has raised significant discussion in the healthcare sector. Healthcare officials have voiced concerns, particularly regarding Kennedy’s history of spreading misinformation and his controversial stance on vaccines. He may advocate for greater scrutiny of medical device approvals, reflecting his general skepticism […]
Read more

AI regulation future in US remains uncertain, says GlobalData

In November 2024, Donald Trump was re-elected as President of the US, with Elon Musk appointed to lead the newly established Department of Efficiency. Musk’s role focuses on streamlining government processes and integrating advanced technologies, a development that marks a significant shift in the regulatory landscape for artificial intelligence (AI) and other emerging technologies. However, […]
Read more

Healthcare collaborations to pave way for enhanced diabetes management in Singapore, says GlobalData

Singapore faces a growing diabetes burden, driven by an aging population, lifestyle changes, and obesity. Traditional management methods such as glucose meters and insulin therapy have limitations, including delayed adjustments in treatment plans and a lack of real-time monitoring, resulting in less effective diabetes control. To bridge these gaps, healthcare providers and technology innovators in […]
Read more

Australia PET imaging systems market to grow at 3.6% CAGR through 2033, forecasts GlobalData

The rising prevalence of chronic diseases, such as cancer and neurological disorders, has driven the demand for advanced diagnostic tools in Australia. Positron Emission Tomography (PET) imaging, renowned for its high-resolution imaging capabilities, plays a vital role in diagnosing oncology, neurology, and cardiology conditions. Several key players are collaborating to deliver precision-focused products for PET […]
Read more

US electrophysiology diagnostic catheter market set to grow at 10% CAGR from 2024 to 2033, forecasts GlobalData

The US electrophysiology (EP) diagnostic catheter market, particularly the segment for advanced EP diagnostic catheters, is projected to experience a robust compound annual growth rate (CAGR) of 10% in market value from 2024 to 2033, forecasts GlobalData, a leading data and analytics company. GlobalData’s report, “Electrophysiology Diagnostic Catheters Market Size by Segments, Share, Regulatory, Reimbursement, […]
Read more

Australia gastroscopes market poised for 7% CAGR through 2033, forecasts GlobalData

Gastrointestinal (GI) cancers, especially in the stomach, colon, and oesophagus, are a major health challenge, impacting millions globally with severe symptoms like abdominal pain, weight loss, and bleeding. Endoscopes play a critical role in the early diagnosis and treatment of these cancers. As Australia is advancing in adopting innovative diagnostic tools, the gastroscopes market is […]
Read more

Canada viscosupplementation market set to grow at over 7.5% CAGR through 2033, forecasts GlobalData

Osteoarthritis (OA) prevalence is on the rise in Canada, driven significantly by an aging population and increasing obesity rates. In response, viscosupplementation—injecting hyaluronic acid directly into the joints—has become a minimally invasive option to manage OA pain and potentially postpone more intensive interventions, like knee replacement surgery. Consequently, the Canada viscosupplementation market is set to […]
Read more

FDA approval for BioIntelliSense’s patient monitoring system marks significant advancement in RPM market, says GlobalData

BioIntelliSense received approval from the US Food and Drug Administration (FDA) in October 2024 for its BioButton Multi-Patient wearable and BioDashboard system, which are designed to enhance virtual care programs in hospitals and extend monitoring capabilities into the home. The development represents a significant advancement in remote patient monitoring (RPM), a need that became crucial […]
Read more

Blood-based biomarker tests the new frontier for Alzheimer’s diagnosis, says GlobalData

Blood-based tests are emerging as valuable tools for the early detection of Alzheimer’s disease, offering accessible alternatives to PET scans and cerebrospinal fluid (CSF) analysis. With Alzheimer’s disease affecting over 55 million people globally, and cases projected to triple by 2050, advances in diagnostic methods are critical for timely intervention. These tests could make diagnosis […]
Read more

US still faces systemic issues in maternal care despite access to advanced medical technology, says GlobalData

Women’s health, specifically maternal care, is a medical device sector that has seen significant growth in recent years. However, there are still several challenges associated with the sector, especially in the US. The US ranks worse than any other developed nation in cases of maternal mortality, despite having access to the most advanced medical technology, […]
Read more
1 … 8 9 10 11 12 … 51